Patrick Lilley is the CEO of Liquid Biosciences. He has spent the last 25 years driving growth and innovation in software, healthcare, big data, and wireless. Patrick is inventor of over 75 patents and trade secrets in bioinformatics, diagnostic biomarkers, signal processing, artificial intelligence, and specialized algorithms. Today he discusses how to use mathematics to accelerate prediction in precision medicine in lung cancer and other diseases.